GSEA analysis revealed that the FSTL1 high-expression group was mostly concentrated in pathways like primary focal segmental glomerulosclerosis (FSGS), nephrotic syndrome, and IL-4 and IL-13 signaling and neutrophil degranulation (Figure 7A). The gene discussed is FSTL1; the disease is focal segmental glomerulosclerosis.